Cargando…
Global Health Innovation Technology Models
Chronic technology and business process disparities between High Income, Low Middle Income and Low Income (HIC, LMIC, LIC) research collaborators directly prevent the growth of sustainable Global Health innovation for infectious and rare diseases. There is a need for an Open Source-Open Science Arch...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998271/ https://www.ncbi.nlm.nih.gov/pubmed/29942382 http://dx.doi.org/10.5772/62921 |
_version_ | 1783331213826588672 |
---|---|
author | Harding, Kimberly |
author_facet | Harding, Kimberly |
author_sort | Harding, Kimberly |
collection | PubMed |
description | Chronic technology and business process disparities between High Income, Low Middle Income and Low Income (HIC, LMIC, LIC) research collaborators directly prevent the growth of sustainable Global Health innovation for infectious and rare diseases. There is a need for an Open Source-Open Science Architecture Framework to bridge this divide. We are proposing such a framework for consideration by the Global Health community, by utilizing a hybrid approach of integrating agnostic Open Source technology and healthcare interoperability standards and Total Quality Management principles. We will validate this architecture framework through our programme called Project Orchid. Project Orchid is a conceptual Clinical Intelligence Exchange and Virtual Innovation platform utilizing this approach to support clinical innovation efforts for multi-national collaboration that can be locally sustainable for LIC and LMIC research cohorts. The goal is to enable LIC and LMIC research organizations to accelerate their clinical trial process maturity in the field of drug discovery, population health innovation initiatives and public domain knowledge networks. When sponsored, this concept will be tested by 12 confirmed clinical research and public health organizations in six countries. The potential impact of this platform is reduced drug discovery and public health innovation lag time and improved clinical trial interventions, due to reliable clinical intelligence and bio-surveillance across all phases of the clinical innovation process. |
format | Online Article Text |
id | pubmed-5998271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-59982712018-06-25 Global Health Innovation Technology Models Harding, Kimberly Nanobiomedicine (Rij) Nanobiomedicine Chronic technology and business process disparities between High Income, Low Middle Income and Low Income (HIC, LMIC, LIC) research collaborators directly prevent the growth of sustainable Global Health innovation for infectious and rare diseases. There is a need for an Open Source-Open Science Architecture Framework to bridge this divide. We are proposing such a framework for consideration by the Global Health community, by utilizing a hybrid approach of integrating agnostic Open Source technology and healthcare interoperability standards and Total Quality Management principles. We will validate this architecture framework through our programme called Project Orchid. Project Orchid is a conceptual Clinical Intelligence Exchange and Virtual Innovation platform utilizing this approach to support clinical innovation efforts for multi-national collaboration that can be locally sustainable for LIC and LMIC research cohorts. The goal is to enable LIC and LMIC research organizations to accelerate their clinical trial process maturity in the field of drug discovery, population health innovation initiatives and public domain knowledge networks. When sponsored, this concept will be tested by 12 confirmed clinical research and public health organizations in six countries. The potential impact of this platform is reduced drug discovery and public health innovation lag time and improved clinical trial interventions, due to reliable clinical intelligence and bio-surveillance across all phases of the clinical innovation process. SAGE Publications 2016-01-01 /pmc/articles/PMC5998271/ /pubmed/29942382 http://dx.doi.org/10.5772/62921 Text en © 2016 Author(s). Licensee InTech. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Nanobiomedicine Harding, Kimberly Global Health Innovation Technology Models |
title | Global Health Innovation Technology Models |
title_full | Global Health Innovation Technology Models |
title_fullStr | Global Health Innovation Technology Models |
title_full_unstemmed | Global Health Innovation Technology Models |
title_short | Global Health Innovation Technology Models |
title_sort | global health innovation technology models |
topic | Nanobiomedicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998271/ https://www.ncbi.nlm.nih.gov/pubmed/29942382 http://dx.doi.org/10.5772/62921 |
work_keys_str_mv | AT hardingkimberly globalhealthinnovationtechnologymodels |